Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes

Cytokine

Volumn 10, Issue 2, 1998, Pages 140-147

  Liu, Tie Fu ^a   Jones, Brian M ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Antibodies; Cytokines; IL 12 production; Lupus

Indexed keywords

INTERLEUKIN 12; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032006062     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0268     Document Type: Article

References (37)

1. 1. Klinman DM, Steinberg AD (1995) Inquiry into murine and human lupus. Immunol Rev 144:157-193.
2. 2. Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NI, Via CS, Shearer GM (1994) T helper cell dysfunction in systemic lupus erythematosus (SLE): Relation to disease activity. J Clin Immunol 14:169-177.
3. 3. Prud'homme GL, Kono DH, Theofilopoulos AN (1995) Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 32:495-503.
4. 4. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Yarela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-844.
5. 5. Houssiau FA, Lefebvre C, Berghe MV, Lambert M, Devogelaer JP, Renauld JC (1995) Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4:393-395.
6. 6. Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H (1992) Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 88:75-83.
7. 7. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117-123.
8. 8. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S (1993) Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 13:58-67.
9. 9. Cicuttini FM, Byron KA, Maher D, Wootton AM, Muirden KD, Hamilton JA (1995) Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheum Int 14:201-206.
10. 10. Horwitz DA, Wang H, Gray JD (1994) Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA. Lupus 3:423-428.
11. 11. Cuadrado MJ, Marubayashi M, Ortega C, Fernandez-Arcas N, Garcia-Cozar F, Pena J, Sanchez-Guijo P, Santamaria M (1993) Relationship of IL-2, IL-2R(CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients. Lupus 2:257-260.
12. 12. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827-845.
13. 13. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808-6812.
14. 14. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, Gately MK (1991) Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88:4143-4147.
15. 15. D'andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398.
16. 16. Lamont AG, Adorini L (1996) IL-12: a key cytokine in immune regulation. Immunol Today 17:214-217.
17. 17. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizzonite R, Gubler U, Stern AS (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL 12 (cytotoxic lymphocyte maturation factor). J Immunol 147:874-882.
18. 18. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G (1994) Interleukin-12 induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 179:1237-1283.
19. 19. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G. (1991) Induction of IFN-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173:869-879.
20. 20. Orange JS, Biron CA (1995) An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. J Immunol 156:1138-1142.
21. 21. Chehimi J, Starr S, Frank I, Rengaraju M, Jackson SJ, Lianes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, Trinchieri G (1992) Natural killer cell stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J Exp Med 175:789-796.
22. 22. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127-142.
23. 23. Hsieh C, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murohy KM (1993) Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
24. 24. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204.
25. 25. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
26. 26. Leonard JP, Waldburger KE, Goldman SJ (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381-386.
27. 27. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR (1995) IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 154:1491-1498.
28. 28. Jones BM (1996) Effect of 12 neutralizing anti-cytokine antibodies on in vitro activation of B-cells. Interleukin-12 is required by B1a but not B2 cells. Scand J Immunol 43:64-72.
29. 29. D'andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041-1048.
30. 30. Doherty TM (1995) T-cell regulation of macrophage function. Cur Opinion in Immunol 7:400-404.
31. 31. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D (1993) Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4:421-427.
32. 32. Spronk PE, Ter-Borg EJ, Limburg PC, Kallenberg CG (1992) Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 90:106-110.
33. 33. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK (1996) Regulation of murine macrophage IL-12 production. J Immunol 156:1196-1206.
34. 34. Chensue SW, Ruth JH, Warmington KW, Lincoln P, Kunkel SL (1995) In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol 155:3546-3551.
35. 35. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277.
36. 36. Bombardier C, Gladman DD, Urowitz MB, Caron D, Caron D, Chang CH, The Committe on Prognosis Studies in SLE (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Reum 35:630-640.
37. 37. Liu TF, Jones BM (1997) Impaired production of IL-12 in system lupus erythematosus. II. IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFNγ and negatively with disease activity in SLE. Cytokine 10:148-153.